Poa Pratensis Pollen Extract

This article discusses clinical trials investigating the use of Poa Pratensis Pollen Extract, also known as Kentucky Blue Grass Pollen Extract, as part of a combination therapy for allergies. While the main focus of the trial is on birch pollen allergy, the study includes Poa Pratensis as one of the components in a grass pollen mix used for skin prick tests. This research aims to evaluate the effectiveness and safety of sublingual immunotherapy for patients with allergic rhinitis and rhinoconjunctivitis.

Table of Contents

What is Poa Pratensis?

Poa pratensis, also known as Kentucky bluegrass, is a type of grass commonly found in many parts of the world. The pollen from this grass can cause allergic reactions in some people. Poa pratensis pollen extract is a substance derived from the pollen of this grass species, which is being studied for its potential use in treating grass pollen allergies[1].

Medical Use

The primary medical use of Poa pratensis pollen extract is in the diagnosis and treatment of grass pollen allergies. It is typically used as part of a mixture with other grass pollen extracts to create diagnostic tools and potential treatments for individuals suffering from allergic rhinitis (hay fever) caused by grass pollen[1].

How It’s Used

Poa pratensis pollen extract can be used in two main ways:

  1. Diagnostic testing: The extract is used in skin prick tests to diagnose grass pollen allergies. A small amount of the allergen is placed on the skin, and if a person is allergic, a small raised bump (wheal) will appear[1].
  2. Immunotherapy: The extract may be used as part of allergen-specific immunotherapy, a treatment aimed at reducing the body’s sensitivity to the allergen over time. This can be administered either through injections (subcutaneous immunotherapy) or under the tongue (sublingual immunotherapy)[1].

Clinical Trial Information

While the clinical trial data provided doesn’t specifically focus on Poa pratensis pollen extract alone, it does mention its use as part of a grass pollen mixture for diagnostic purposes. The trial described is studying the effectiveness of sublingual immunotherapy for birch pollen allergy, but it uses a grass pollen mix (including Poa pratensis) for skin prick testing to assess patients’ overall allergy profiles[1].

The grass pollen mix used in the trial includes:

  • Timothy grass pollen extract
  • Lolium perenne (ryegrass) pollen extract
  • Poa pratensis (Kentucky bluegrass) pollen extract
  • Festuca elatior (tall fescue) pollen extract
  • Dactylis glomerata (cocksfoot) pollen extract

This mixture is used in a solution for skin prick testing, with a concentration of 30 HEP/ml (HEP stands for Histamine Equivalent Prick, a measure of allergen potency)[1].

Potential Benefits

While the clinical trial doesn’t directly study the effects of Poa pratensis pollen extract treatment, the use of grass pollen extracts in immunotherapy has shown potential benefits for individuals with grass pollen allergies:

  • Reduction in allergy symptoms
  • Decreased need for allergy medications
  • Improved quality of life during pollen seasons
  • Potential long-term modification of the allergic response

Considerations and Precautions

It’s important to note that while Poa pratensis pollen extract can be beneficial for diagnosing and treating grass pollen allergies, it should only be used under the supervision of a healthcare professional. Some considerations include:

  • Allergic reactions: As with any allergen, there’s a risk of allergic reactions, including severe ones (anaphylaxis), especially during initial testing or treatment[1].
  • Cross-reactivity: People allergic to one type of grass pollen may react to others due to similarities in the pollen structure[1].
  • Individual response: The effectiveness of immunotherapy can vary from person to person.
  • Long-term commitment: Immunotherapy typically requires a long-term treatment plan, often lasting several years.

Always consult with an allergist or immunologist to determine if treatments using Poa pratensis pollen extract or other grass pollen extracts are appropriate for your specific allergy profile and health condition.

Aspect Details
Study Type Phase II-III clinical trial
Main Focus Efficacy and safety of sublingual immunotherapy for birch pollen allergy
Poa Pratensis Pollen Extract Role Component in grass pollen mix for skin prick tests
Primary Endpoint Differences in mean CSMS during Peak Birch Pollen Period between active and placebo groups
Key Inclusion Criteria Adults 18-65 years, moderate-to-severe allergic rhinitis/rhinoconjunctivitis due to birch pollen
Key Exclusion Criteria Recent immunotherapy, severe lung diseases, severe asthma, immune system disorders
Safety Assessments Treatment-Emergent Adverse Drug Reactions (TEADR)

Ongoing Clinical Trials on Poa Pratensis Pollen Extract

  • Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

    Not yet recruiting

    3 1
    Portugal Spain
  • Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

    Not yet recruiting

    3 1
    Portugal Spain
  • Study on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy

    Not recruiting

    4 1 1
    Investigated diseases:
    Germany

Glossary

  • Allergic rhinitis: An allergic reaction that causes inflammation in the nose, leading to symptoms such as sneezing, runny nose, and nasal congestion.
  • Rhinoconjunctivitis: A combination of rhinitis (inflammation of the nasal passages) and conjunctivitis (inflammation of the eye's conjunctiva), often caused by allergies.
  • Sublingual immunotherapy: A form of allergy treatment where small doses of allergens are placed under the tongue to help the body build tolerance over time.
  • Skin prick test: A method used to diagnose allergies by placing a small amount of a suspected allergen on the skin and then pricking the skin to allow the substance to enter. A positive reaction indicates an allergy.
  • CSMS (Combined Symptom and Medication Score): A measure used in allergy studies to assess the severity of symptoms and the need for medication.
  • FEV1 (Forced Expiratory Volume in 1 second): A measure of lung function that represents the amount of air a person can forcefully exhale in one second.
  • IgE (Immunoglobulin E): An antibody produced by the immune system in response to allergens, often elevated in people with allergies.
  • ARIA guideline: Allergic Rhinitis and its Impact on Asthma guideline, a set of recommendations for diagnosing and managing allergic rhinitis.
  • GINA guideline: Global Initiative for Asthma guideline, a resource for managing and preventing asthma.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-sublingual-immunotherapy-with-betula-pendula-pollen-extract-for-patients-with-birch-pollen-allergy/